Pigmented Villonodular Synovitis
The etiology of pigmented villonodular synovitis (PVNS) remains controversial. It presents as an infammatory synovial diseasee usually involving only one ointe but histologically the disease demonstrates histiocytic proliferation in the subsynovial tissue that takes on characteristics of a neoplastic condition similar to a giant cell tumor. PVNS occurs typically in the subsynovial tissue about ma or oints of the lower extremity in patients between the ages of 20 and 40 years. The knee oint is the most common sitee followed next by the hipe ankle and foot. It is rare to see this disease in the upper extremity. The histiocytic proliferation in subsynovial tissues is similar to that seen in giant cell tumor of tendon sheathes in the hand and foot. The clinical picture in the knee oint is that of spontaneous swelling associated with pain and synovial hypertrophy. Hemarthrosis can result in massive swelling about the knee oint and can occasionally result in uxta-articular erosion of bonee similar to what is seen in rheumatoid synovitis. Clinical conditions with a similar presentation include hemophilia and coccidioidomycosis. In fewer than ten per cent of cases this condition will present as a localized focal mass in the suprapatellar pouch of the knee or high in the popliteal space posteriorly and can masquerade as a neoplastic condition such as a synovial sarcoma.
Treatment for the more generalized synovial involvement of the knee oint or other lower extremity oints consists of a subtotal synovectomy ofen performed through an arthroscope. In more extensive cases an open procedure may be necessary. The recurrence rate is fairly highe in the range of 30 per cent. In cases where multiple recurrences resulte treatment with external beam radiation therapy in the neighborhood of 1500 -3000 rads is used. In ectable isotopes have also been used for radiation treatment of recurrent cases. Secondary arthritic changese especially in the knee ointe can occur as a late complication of this disease and these changes could lead to a total oint replacement at the age of 50 or 60 years. On very rare occasionse this disease can convert to a neoplastic sarcoma with a high degree of giant cell activity. This is similar to the conversion of a giant cell tumor to a malignant sarcoma.
